These Analysts Revise Their Forecasts On Lowe’s After Q2 Results

Lowe's Companies Inc (NYSE: LOW) reported better-than-expected second-quarter earnings and reaffirmed FY23 outlook.

Lowe’s Companies Inc (NYSE:LOW) reported better-than-expected second-quarter earnings and reaffirmed FY23 outlook.

Lowe’s reported a second-quarter FY23 sales decline of 9.17% year-on-year to $24.96 billion, marginally missing the analyst consensus of $24.99 billion. EPS of $4.56 beat the analyst consensus estimate of $4.49.

Lowe’s reaffirmed its FY23 revenue outlook of $87 billion – $89 billion, against the Street view of $88.08 billion. It sees FY23 adjusted EPS of $13.20 – $13.60 against the consensus of $13.37.

Lowe’s shares rose 0.1% to trade at $225.93 on Wednesday.

These analysts made changes to their price targets on Lowe’s following earnings announcement.

  • Telsey Advisory Group boosted the price target on Lowe’s from $225 to $230. Telsey Advisory Group analyst Joseph Feldman maintained a Market Perform rating.
  • Goldman Sachs lowered the price target on Lowe’s from $260 to $252. Goldman Sachs analyst Kate McShane maintained a Buy rating.
  • Baird raised the price target on Lowe’s from $225 to $250. Baird analyst Peter Benedict maintained an Outperform rating.
  • Wells Fargo increased the price target on Lowe’s from $245 to $250. Wells Fargo analyst Zachary Fadem maintained an Overweight rating.
  • UBS raised the price target on Lowe’s from $250 to $265. UBS analyst Michael Lasser maintained a Buy rating.
Total
0
Shares
Related Posts
Read More

Are Psychedelics A Threat To Alcohol And Tobacco Industries? A Glance At Thriving Advances

As the attachment to both tobacco and alcohol is deeply rooted and likely intertwined with other human and societal factors, it is evident these behaviors are complex to analyze.  And yet, the near future seems to hold hope for those ready and willing to disengage from these practices. The formula would include patience, support and psychedelics.

NFLX